FDA Advisory: Daratumumab Wins, Glofitamab Loses
Medscape,
Daratumumab and hyaluronidase (Darzalex Faspro, Johnson
Daratumumab and hyaluronidase (Darzalex Faspro, Johnson
Oncology/Hematology > Hematology Glofitamab for earlier lymphoma use gets thumbs down from FDA panel for lack of U.S.
Actor John J. York is doing his best to make the best of a serious health issue.
Actor John J. York is doing his best to make the best out of a serious health concern.